ArticleCancer immunology research2023
EDIL3 as an Angiogenic Target of Immune Exclusion Following Checkpoint Blockade.
Saba Tabasum et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
22 papers cite it
this papercites it
ArticleCancer immunology research2023
Saba Tabasum et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.